Detalles de la búsqueda
1.
Germline TP53 mutational spectrum in French Canadians with breast cancer.
BMC Med Genet
; 16: 24, 2015 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-25925845
2.
The BRCA2 c.9004G>A (E2002K) [corrected] variant is likely pathogenic and recurs in breast and/or ovarian cancer families of French Canadian descent.
Breast Cancer Res Treat
; 131(1): 333-40, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21947752
3.
Derivation and characterization of matched cell lines from primary and recurrent serous ovarian cancer.
BMC Cancer
; 12: 379, 2012 Aug 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-22931248
4.
The Genetic and Molecular Analyses of RAD51C and RAD51D Identifies Rare Variants Implicated in Hereditary Ovarian Cancer from a Genetically Unique Population.
Cancers (Basel)
; 14(9)2022 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35565380
5.
Investigating the causal role of MRE11A p.E506* in breast and ovarian cancer.
Sci Rep
; 11(1): 2409, 2021 01 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-33510186
6.
A functionally impaired missense variant identified in French Canadian families implicates FANCI as a candidate ovarian cancer-predisposing gene.
Genome Med
; 13(1): 186, 2021 12 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34861889
7.
The chemiluminescence based Ziplex automated workstation focus array reproduces ovarian cancer Affymetrix GeneChip expression profiles.
J Transl Med
; 7: 55, 2009 Jul 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-19580657
8.
Haplotype analysis of TP53 polymorphisms, Arg72Pro and Ins16, in BRCA1 and BRCA2 mutation carriers of French Canadian descent.
BMC Cancer
; 8: 96, 2008 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-18402691
9.
Characterization of three new serous epithelial ovarian cancer cell lines.
BMC Cancer
; 8: 152, 2008 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-18507860
10.
Global analysis of chromosome X gene expression in primary cultures of normal ovarian surface epithelial cells and epithelial ovarian cancer cell lines.
Int J Oncol
; 30(1): 5-17, 2007 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17143508
11.
Functionally Null RAD51D Missense Mutation Associates Strongly with Ovarian Carcinoma.
Cancer Res
; 77(16): 4517-4529, 2017 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28646019
12.
Haplotype analysis suggest common founders in carriers of the recurrent BRCA2 mutation, 3398delAAAAG, in French Canadian hereditary breast and/ovarian cancer families.
BMC Med Genet
; 7: 23, 2006 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16539696
13.
OGG1 Cys326 variant, allelic imbalance of chromosome band 3p25.3 and TP53 mutations in ovarian cancer.
Int J Oncol
; 27(5): 1315-20, 2005 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-16211227
14.
Double PALB2 and BRCA1/BRCA2 mutation carriers are rare in breast cancer and breast-ovarian cancer syndrome families from the French Canadian founder population.
Oncol Lett
; 9(6): 2787-2790, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26137147
15.
Novel high-grade serous epithelial ovarian cancer cell lines that reflect the molecular diversity of both the sporadic and hereditary disease.
Genes Cancer
; 6(9-10): 378-398, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26622941
16.
A targeted analysis identifies a high frequency of BRCA1 and BRCA2 mutation carriers in women with ovarian cancer from a founder population.
J Ovarian Res
; 8: 1, 2015 Mar 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-25884701
17.
Analysis of genomic abnormalities in tumors: a review of available methods for Illumina two-color SNP genotyping and evaluation of performance.
Cancer Genet
; 206(4): 103-15, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23623180
18.
Small cell ovarian carcinoma: genomic stability and responsiveness to therapeutics.
Orphanet J Rare Dis
; 8: 33, 2013 Feb 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-23433318
19.
VGLL3 expression is associated with a tumor suppressor phenotype in epithelial ovarian cancer.
Mol Oncol
; 7(3): 513-30, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23415753
20.
The genomic landscape of TP53 and p53 annotated high grade ovarian serous carcinomas from a defined founder population associated with patient outcome.
PLoS One
; 7(9): e45484, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23029043